Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 118 $ 40,770,504 $ (16,289,077) $ 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (decrease) in stockholders' equity        
Shares issued upon exercise of warrants, net of issuance costs [1] $ 20 9,274,891   9,274,911
Shares issued upon exercise of warrants, net of issuance costs (in shares) [1] 2,047,361      
Stock-based compensation: Common stock $ 1 513,102   513,103
Stock-based compensation: Common stock (in shares) 70,040      
Stock-based compensation: Options   2,576   2,576
Net loss     (1,796,612) (1,796,612)
Balance at the end at Mar. 31, 2021 $ 139 50,561,073 (18,085,689) 32,475,523
Balance at the end (in shares) at Mar. 31, 2021 13,873,510      
Balance at the beginning at Dec. 31, 2020 $ 118 40,770,504 (16,289,077) 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (decrease) in stockholders' equity        
Net loss       (5,810,230)
Balance at the end at Sep. 30, 2021 $ 143 51,827,263 (22,099,307) 29,728,099
Balance at the end (in shares) at Sep. 30, 2021 14,252,886      
Balance at the beginning at Mar. 31, 2021 $ 139 50,561,073 (18,085,689) 32,475,523
Balance at the beginning (in shares) at Mar. 31, 2021 13,873,510      
Increase (decrease) in stockholders' equity        
Shares issued upon exercise of warrants, net of issuance costs [2] $ 1 428,718   428,719
Shares issued upon exercise of warrants, net of issuance costs (in shares) [2] 108,961      
Stock-based compensation: Common stock $ 2 27,568   27,570
Stock-based compensation: Common stock (in shares) 167,600      
Stock-based compensation: Options   2,509   2,509
Common stock issued upon exercise of options   8,361   8,361
Common stock issued upon exercise of options (in shares) 2,815      
Shares issued as partial consideration for intangible asset $ 1 531,999   532,000
Shares issued as partial consideration for intangible asset (in shares) 100,000      
Net loss     (1,703,005) (1,703,005)
Balance at the end at Jun. 30, 2021 $ 143 51,560,228 (19,788,694) 31,771,677
Balance at the end (in shares) at Jun. 30, 2021 14,252,886      
Increase (decrease) in stockholders' equity        
Stock-based compensation: Options   2,533   2,533
Common stock issued upon exercise of options   264,502   264,502
Net loss     (2,310,613) (2,310,613)
Balance at the end at Sep. 30, 2021 $ 143 51,827,263 (22,099,307) 29,728,099
Balance at the end (in shares) at Sep. 30, 2021 14,252,886      
Balance at the beginning at Dec. 31, 2021 $ 143 52,030,907 (26,580,790) 25,450,260
Balance at the beginning (in shares) at Dec. 31, 2021 14,253,948      
Increase (decrease) in stockholders' equity        
Surrender and cancellation of common stock   (18,683)   (18,683)
Surrender and cancellation of common stock (in shares) (3,397)      
Stock-based compensation: Options   2,295   2,295
Common stock issued upon exercise of options   430,361   430,361
Common stock issued upon exercise of options (in shares) 53,192      
Net loss     (3,627,492) (3,627,492)
Balance at the end at Mar. 31, 2022 $ 143 52,444,880 (30,208,282) 22,236,741
Balance at the end (in shares) at Mar. 31, 2022 14,303,743      
Balance at the beginning at Dec. 31, 2021 $ 143 52,030,907 (26,580,790) 25,450,260
Balance at the beginning (in shares) at Dec. 31, 2021 14,253,948      
Increase (decrease) in stockholders' equity        
Net loss       (11,111,547)
Balance at the end at Sep. 30, 2022 $ 144 52,891,794 (37,692,337) 15,199,601
Balance at the end (in shares) at Sep. 30, 2022 14,402,500      
Balance at the beginning at Mar. 31, 2022 $ 143 52,444,880 (30,208,282) 22,236,741
Balance at the beginning (in shares) at Mar. 31, 2022 14,303,743      
Increase (decrease) in stockholders' equity        
Surrender and cancellation of common stock   (36,188)   (36,188)
Surrender and cancellation of common stock (in shares) (8,323)      
Stock-based compensation: Options   2,067   2,067
Common stock issued upon exercise of options $ 1 308,950   308,951
Common stock issued upon exercise of options (in shares) 105,832      
Net loss     (5,809,891) (5,809,891)
Balance at the end at Jun. 30, 2022 $ 144 52,719,709 (36,018,173) 16,701,680
Balance at the end (in shares) at Jun. 30, 2022 14,401,252      
Increase (decrease) in stockholders' equity        
Stock-based compensation: Options   2,236   2,236
Common stock issued upon exercise of options   169,849   169,849
Common stock issued upon exercise of options (in shares) 1,248      
Net loss     (1,674,164) (1,674,164)
Balance at the end at Sep. 30, 2022 $ 144 $ 52,891,794 $ (37,692,337) $ 15,199,601
Balance at the end (in shares) at Sep. 30, 2022 14,402,500      
[1] Includes gross proceeds of $9,708,038, less issuance costs of $433,127.
[2] Includes gross proceeds of $460,989, less issuance costs of $32,270.